Graft rejection mechanisms

All of the host-mediated, antitumor polysaccharides so far noted have been isolated and identified, based on a bio-assay system normally using Sarcoma 180 in mice. The allogeneic, tumor-graft rejection-mechanism is the basis of this system. 

Allograft rejection mechanisms for increasing graft acceptance... 

Voclosporin (ISA-247, R1524) 88 (Isotechnika) is being evaluated in a Phase III trial for the treatment of psoriasis,250 as well as a Phase III trial by Lux Biosciences as for the treatment of uveitis (coded as LX211, Luveniq ).251,252 In addition, voclosporin 88 has completed a Phase lib trial for the prevention of kidney graft rejection. Voclosporin 88253,254 is a slightly more potent but less toxic semi-synthetic derivative of the fungal-derived immunosuppressant cyclosporin A 89, which has the same mechanism of calcineurin inhibition. Cyclosporin A 89 was first isolated from Tolypocladium inflatum by workers at Sandoz and its structure was published in 1976.255,256... 

Astralagus 2. Echinacea 3. Liquorice 4. Milk thistle 5. Neem 6. Sea buckthorn 1. Ciclosporin 2. Azathioprine 3. Methotrexate 4. Tacrolimus 5. Dadizumab 6. Cyclophosphamide Possibility of graft rejection 1 blood level unknown mechanism (astralagus). Other mechanisms alkyl amides from echinacea modulate tumour necrosis factor alpha mRNA expression in human monocytes/macrophages via the cannabinoid type 2 receptor Unknown mechanism (milk thistle is known to l cyclosporine levels neem L effects of azathioprine, prednisolone and dadizumab sea buckthorn may 1 effect of cyclophosphamide) Induces metabolizing enzymes, CYP3A4 and P-gp (St John s wort L ciclosporin and tacrolimus levels) Avoid concomitant use of the herb... 

Interactions of transfusion with transplantation can occur (200). Blood transfusions, and especially donor-specific transfusions, given before kidney transplantation have beneficial effects on graft survival the mechanism for this is not known (201-203). By contrast, pre-transplant transfusions in bone marrow recipients with aplastic anemia cause major complications, and can be responsible for graft rejection and marrow transplantation failure (204). 

The sequence of events that underlies graft rejection is recognition of the donor s histocompatibility differences by the recipient s immune system, recruitment of activated lymphocytes, initiation of immune effector mechanisms, and Anally graft destruction. 

Acute cellular rejection involves infiltration of macrophages and lymphocytes into the graft and is evident from the necrosis of the parenchymal cells of the graft. The lysis of the parenchymal cells of the transplanted tissue is achieved by the infiltrating leukocytes. Acute cellular rejection may be the product of several mechanisms including cytolytic T-cell-mediated lysis, NK cell-mediated lysis and activated macrophage-mediated lysis. The acute cellular rejection predominantly involves CD8+ T cytolytic cells that kill the grafted tissue. 

---